共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R029174-50mg | 50mg | 5~7个工作日 |
BMS-626529 BMS-626529 |
98% |
|
|
罗恩 | R029174-5mg | 5mg | 5~7个工作日 |
BMS-626529 BMS-626529 |
98% |
|
|
罗恩 | R029174-10mg | 10mg | 5~7个工作日 |
BMS-626529 BMS-626529 |
98% |
|
|
阿拉丁 | B126941-5mg | 5mg | 现货 |
Temsavir (BMS-626529) BMS-626529 |
≥98% |
|
|
阿拉丁 | B126941-10mg | 10mg | 现货 |
Temsavir (BMS-626529) BMS-626529 |
≥98% |
|
|
阿拉丁 | B126941-50mg | 50mg | 现货 |
Temsavir (BMS-626529) BMS-626529 |
≥98% |
|
|
阿拉丁 | B425591-1ml | 1ml | 现货 |
BMS-626529 BMS-626529 |
10mM in DMSO |
|
|
凯为 | JZ00FCZO-100mg | 100mg | 期货,请咨询 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... BMS 626529 |
98% |
|
|
凯为 | JZ00FCZO-250mg | 250mg | 期货,请咨询 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... BMS 626529 |
98% |
|
|
凯为 | JZ00FCZO-1g | 1g | 期货,请咨询 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... BMS 626529 |
98% |
|
|
凯为 | JZ00FCZO-10mg | 10mg | 期货,请咨询 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... BMS 626529 |
98% |
|
|
凯为 | JZ00FCZO-25mg | 25mg | 期货,请咨询 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... BMS 626529 |
98% |
|
|
凯为 | JZ00FCZO-50mg | 50mg | 期货,请咨询 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... BMS 626529 |
98% |
|
|
毕得 | BD304088-10mg | 10mg | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... 1-(4-Benzoylpiperazin-1-yl)-... |
98% |
|
|
毕得 | BD304088-50mg | 50mg | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... 1-(4-Benzoylpiperazin-1-yl)-... |
98% |
|
|
毕得 | BD304088-100mg | 100mg | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... 1-(4-Benzoylpiperazin-1-yl)-... |
98% |
|
|
毕得 | BD304088-25mg | 25mg | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... 1-(4-Benzoylpiperazin-1-yl)-... |
98% |
|
|
毕得 | BD304088-250mg | 250mg | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... 1-(4-Benzoylpiperazin-1-yl)-... |
98% |
|
|
毕得 | BD304088-1g | 1g | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-(-甲氧基-7-(... 1-(4-Benzoylpiperazin-1-yl)-... |
98% |
|
|
韶远 | SY242178-0.25g | 0.25g | 现货 |
1-(4-苯甲酰基哌嗪-1-基)-2-[4-甲氧基-7-... 1-(4-Benzoylpiperazin-1-yl)-... |
≥95% |
|
|
源叶 | S86260-5mg | 5mg | 期货,请咨询 |
Temsavir (BMS-626529) BMS-626529 |
≥98% |
|
|
源叶 | S86260-10mg | 10mg | 期货,请咨询 |
Temsavir (BMS-626529) BMS-626529 |
≥98% |
|
|
源叶 | S86260-50mg | 50mg | 期货,请咨询 |
Temsavir (BMS-626529) BMS-626529 |
≥98% |
|
|
源叶 | S53606-1ml | 1ml | 期货,请咨询 |
BMS-626529 BMS-626529 |
10mM in DMSO |
|
|
Target Mol | T4665-5mg | 5mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-10mg | 10mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-25mg | 25mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-50mg | 50mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-1mL | 1mL | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-100mg | 100mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-1mg | 1mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Target Mol | T4665-200mg | 200mg | 现货 |
化合物 BMS626529 Temsavi |
98.06% |
|
|
Am | A128252-50mg | 50mg | 现货 |
Temsavir Temsavi |
98% |
|
|
Am | A128252-2mg | 2mg | 现货 |
Temsavir Temsavi |
98% |
|
|
Am | A128252-25mg | 25mg | 现货 |
Temsavir Temsavi |
98% |
|
|
Am | A128252-1mg | 1mg | 现货 |
Temsavir Temsavi |
98% |
|
|
Am | A128252-100mg | 100mg | 现货 |
Temsavir Temsavi |
98% |
|
|
Am | A128252-10mg | 10mg | 现货 |
Temsavir Temsavi |
98% |
|
|
Am | A128252-5mg | 5mg | 现货 |
Temsavir Temsavi |
98% |
|
|
MCE | HY-15440-100mg | 100mg | 现货 |
Temsavir Temsavi |
98.06% |
|
|
MCE | HY-15440-50mg | 50mg | 现货 |
Temsavir Temsavi |
98.06% |
|
|
MCE | HY-15440-10mg | 10mg | 现货 |
Temsavir Temsavi |
98.06% |
|
|
MCE | HY-15440-10mM*1mL | 10mM*1mL | 现货 |
Temsavir Temsavi |
98.06% |
|
|
MCE | HY-15440-5mg | 5mg | 现货 |
Temsavir Temsavi |
98.06% |
|
|
MCE | HY-15440-2mg | 2mg | 现货 |
Temsavir Temsavi |
98.06% |
|
|